Bartosz Chmielowski

Ronald Reagan UCLA Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (9)

Joseph J. Sacco

Clinical Senior Lecturer

University of Liverpool

UNITED KINGDOM

View details

Bruno Vincenzi

Professor of Medical Oncology

Università Campus Bio-Medico

ITALY

View details

Jonathan W. Goldman

Associate Professor

UCLA

UNITED STATES

View details

John Kirkwood

Distinguished Service Professor of Medicine

University of Pittsburgh

UNITED STATES

View details

Ezra Cohen

Professor of Medicine

Moores Cancer Center, UC San Diego Health

UNITED STATES

View details

Mohammed Milhem

Oncology Section Chief

University of Iowa Healthcare

UNITED STATES

View details

David S. Hong

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Robert G. Maki

Professor, Member

UNITED STATES

View details

Georgia Beasley

Associate Professor

Duke University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bartosz Chmielowski

Research Interests

Explore related searches

Contact this professor

Articles (11)

RP1 Combined With Nivolumab in Advanced Anti–PD-1–Failed Melanoma (IGNYTE)

Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy

Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Preclinical and Clinical Trial Results Using Talazoparib and Low-Dose Chemotherapy

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Collaborators (9)

Joseph J. Sacco

Bruno Vincenzi

Jonathan W. Goldman

John Kirkwood

Ezra Cohen

Mohammed Milhem

David S. Hong

Robert G. Maki

Georgia Beasley

Make your next move.